Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHBRN.L Regulatory News (HBRN)

  • There is currently no data for HBRN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 38.5b - Hibernia Reit plc

16 Jun 2022 11:50

RNS Number : 1620P
GoldmanSachs International
16 June 2022
 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

HIBERNIA REIT PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.10 ordinary shares

Date of dealing

15 June 2022

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

8,900

(0.00)

16,555

(0.00)

(2) Derivatives (other than options)

0

(0.00)

0

(0.00)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

8,900

(0.00)

16,555

(0.00)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

3. DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Sale (Borrow Full Return)

12,000

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)

 

(d) Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9) NO

 

Date of disclosure

16 June 2022

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

Name of offeree/offeror with which connected

BENEDICT REAL ESTATE BIDCO LIMITED, A SUBSIDIARY OF ONE OF BROOKFIELD ASSET MANAGEMENT'S REAL ESTATE PRIVATE FUNDS.

Nature of connection (Note 9)

Advisor to Offeree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEAEKKFLPAEFA
Date   Source Headline
18th Sep 20207:00 amEQSTransactions in own shares
17th Sep 20207:01 amEQSTransactions in own shares
16th Sep 20207:00 amEQSTransactions in own shares
15th Sep 20207:00 amEQSTransactions in own shares
14th Sep 20207:00 amRNSTransactions in own shares
11th Sep 20207:00 amRNSTransactions in own shares
10th Sep 20207:00 amRNSTransactions in own shares
9th Sep 20207:00 amRNSTransactions in own shares
8th Sep 20207:00 amRNSTransactions in own shares
7th Sep 20207:00 amRNSTransaction in Own Shares
4th Sep 20207:00 amRNSTransaction in Own Shares
3rd Sep 20207:00 amRNSTransaction in Own Shares
2nd Sep 20207:00 amRNSTransactions in own shares
1st Sep 20207:00 amRNSTransaction in Own Shares
28th Aug 20205:40 pmRNSTransaction in Own Shares
28th Aug 20207:00 amRNSTransactions in own shares
27th Aug 20207:00 amRNSTransactions in own shares
26th Aug 20207:00 amRNSTransactions in own shares
25th Aug 20207:00 amEQSTransactions in own shares
24th Aug 20207:00 amRNSTransactions in Own Shares
21st Aug 20207:00 amRNSTransactions in Own Shares
20th Aug 20207:00 amRNSTransactions in Own Shares
19th Aug 20207:00 amRNSTransactions in Own Shares
18th Aug 20207:00 amRNSTransactions in Own Shares
17th Aug 20207:00 amRNSTransactions in Own Shares
14th Aug 20207:00 amRNSTransactions in Own Shares
13th Aug 20207:00 amRNSTransactions in Own Shares
12th Aug 20207:00 amRNSTransactions in Own Shares
11th Aug 20207:00 amRNSTransactions in Own Shares
10th Aug 20207:00 amRNSTransactions in Own Shares
7th Aug 20207:00 amRNSShare buyback announcement
6th Aug 20208:15 amRNSDirector/PDMR Shareholding
31st Jul 20203:15 pmRNSLong-Term Incentive Plan (“LTIP”) grant
29th Jul 20203:10 pmRNSAGM Results Announcement
29th Jul 20207:00 amRNSHibernia REIT plc Trading Update
24th Jul 20205:45 pmRNSHolding(s) in Company
16th Jul 20201:00 pmRNSInformation regarding Annual General Meeting
10th Jul 202012:35 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSRent Update
30th Jun 20209:45 amRNSDirector/PDMR Shareholding
26th Jun 20204:15 pmRNSNotice of AGM
19th Jun 20207:00 amRNSDirectorate Change
2nd Jun 202012:01 pmRNSHolding(s) in Company
27th May 20207:00 amRNSPreliminary results for the year to 31 March 2020
15th May 202011:00 amRNSHolding(s) in Company
14th May 20202:40 pmRNSHolding(s) in Company
14th May 20209:25 amRNSHolding(s) in Company
12th May 20203:50 pmRNSHolding(s) in Company
29th Apr 20209:55 amRNSHolding(s) in Company
24th Apr 20204:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.